Furthermore, H19 is associated with key clinical factors such as tumor size, clinical stage, lymph node metastasis, distant metastasis, and overall survival (OS), with studies suggesting its potential as biomarker in the progression of tumors [45,67]. Here, H19 is linked to neoplasm.